헤모글로빈 검사 시장 보고서 : 제품 유형, 기술, 최종사용자, 지역별(2025-2033년)

The global hemoglobin testing market size reached USD 2.55 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.12 Billion by 2033, exhibiting a growth rate (CAGR) of 5.22% during 2025-2033. An increase in chronic conditions, including diabetes and anemia, is stimulating the market.

Hemoglobin Testing Market Trends:

Rising Demand for Point-of-Care Testing

The shift to point-of-care testing (POCT) is a significant development in the hemoglobin monitoring market as it provides quick, convenient testing outside of traditional labs. Portable analyzers deliver quick results, which improves patient care and decision-making. In June 2024, Horiba launched new compact hematology analyzers, namely, Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube). They offer combined testing for CBC/DIFF with ESR results from whole blood in 60 seconds.

Growing Use of Artificial Intelligence (AI) in Diagnostics

The hemoglobin testing market overview is exploring AI, which is rapidly being used in hemoglobin testing to improve accuracy and efficiency. AI-powered systems can swiftly evaluate big datasets, minimizing human error and improving diagnosis accuracy. This is one of the hemoglobin testing market drivers. In August 2024, IIT Kharagpur collaborated with Sathya Sai Hospital for AI-powered anemia screening. This joint effort focuses on developing innovative solutions to address the challenges of anemia in underprivileged populations.

Increasing Awareness and Screening for Anemia

Early identification of anemia, a disorder associated with low hemoglobin levels, is becoming increasingly important. Governments and health organizations around the world are launching screening programs to identify anemia in susceptible populations, such as pregnant women and children. In February 2024, the Indian Academy of Pediatrics (IAP) launched a nationwide campaign to raise awareness about anemia and other crucial child health issues.

Global Hemoglobin Testing Industry Segmentation:

Breakup by Product Type:

• Reagents and Consumables
• Equipment

As per the hemoglobin testing market share analysis, reagents and consumables, such as test strips and other disposable materials, have a strong presence in the market due to their widespread use in diagnostic procedures. The equipment segment, which includes analyzers and point-of-care devices, is experiencing considerable growth due to technical developments and rising demand for portable testing solutions.

Breakup by Technology:

• Chromatography
• Immunoassay
• Others

Chromatography is frequently utilized for precise and thorough hemoglobin variant analysis, especially in laboratory settings where precision is crucial. Meanwhile, immunoassay technology is gaining popularity because of its speed and cost-effectiveness, making it ideal for point-of-care testing and routine hemoglobin monitoring in a variety of healthcare settings. These segments are contributing to shaping hemoglobin testing market dynamics.

Breakup by End-User:

• Laboratories
• Hospitals
• Research Centers

According to the hemoglobin testing industry statistics, laboratories hold a considerable proportion due to their ability to do high-volume testing and extensive analysis. Hospitals play an important role in hemoglobin testing for patient diagnosis and monitoring. Moreover, research institutions contribute to market growth by developing new testing methods and diagnostic technologies.

Breakup by Region:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

As per the hemoglobin testing market outlook, advanced healthcare systems and extensive diagnostic tool usage are pushing the market in North America. Europe benefits from strong government healthcare assistance and heightened awareness of early detection. Asia Pacific is experiencing rapid growth due to its large population, rising healthcare awareness, and improving medical infrastructure. In Latin America, the market is growing as healthcare systems improve and focus on malnutrition-related illnesses. The Middle East and Africa region is evolving, with more access to healthcare, increased investment in diagnostics, and initiatives to tackle regional health challenges such as anemia.

Competitive Landscape:

The research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Abbott Laboratories
• Bio-Rad Laboratories
• Danaher
• EKF Diagnostics
• F. Hoffmann-La Roche
• Siemens Healthineers
• Thermo Fisher Scientific
• Alere
• ACON Laboratories
• ARKRAY
• Bayer Medical Care
• Daiichi Biotech
• DiaSys Diagnostic Systems
• Epinex Diagnostics
• Erba Diagnostics

Key Questions Answered in This Report

• 1.How big is the hemoglobin testing market?
• 2.What is the future outlook of hemoglobin testing market?
• 3.What are the key factors driving the hemoglobin testing market?
• 4.Which region accounts for the largest hemoglobin testing market share?
• 5.Which are the leading companies in the global hemoglobin testing market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Hemoglobin Testing Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Product Type
• 5.5 Market Breakup by Technology
• 5.6 Market Breakup by End-User
• 5.7 Market Breakup by Region
• 5.8 Market Forecast

6 Market Breakup by Product Type

• 6.1 Reagents and Consumables
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Equipment
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Chromatography
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Immunoassay
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End-User

• 8.1 Laboratories
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Hospitals
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Research Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 Europe
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 North America
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Asia Pacific
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Middle East and Africa
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Latin America
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories
  • 14.3.2 Bio-Rad Laboratories
  • 14.3.3 Danaher
  • 14.3.4 EKF Diagnostics
  • 14.3.5 F. Hoffmann-La Roche
  • 14.3.6 Siemens Healthineers
  • 14.3.7 Thermo Fisher Scientific
  • 14.3.8 Alere
  • 14.3.9 ACON Laboratories
  • 14.3.10 ARKRAY
  • 14.3.11 Bayer Medical Care
  • 14.3.12 Daiichi Biotech
  • 14.3.13 DiaSys Diagnostic Systems
  • 14.3.14 Epinex Diagnostics
  • 14.3.15 Erba Diagnostics